Nivolumab-induced lichen planus responsive to dupilumab treatment in a patient with stage III C melanoma

JAAD Case Rep. 2023 Jun 5:38:23-26. doi: 10.1016/j.jdcr.2023.05.036. eCollection 2023 Aug.

Authors

Sarah Kamsiah Zemlok¹, Sulaikha Buuh¹, Regina Brown², Michael Murphy², Upendra P Hegde³, Janelle R Mallett²

Affiliations

¹ Department of Dermatology, University of Connecticut School of Medicine, Farmington, Connecticut.
² Department of Dermatology, University of Connecticut, Farmington, Connecticut.
³ Department of Hematology and Oncology, Neag Comprehensive Cancer Center, University of Connecticut, Farmington, Connecticut.

No abstract available

Keywords: delayed drug reaction; dupilumab; immune-related adverse effects; lichen planus; nivolumab.

Publication types

Case Reports